Investor Growth Capital Limited
VC Fund
Stockholm, Sweden
Investor Growth Capital Limited is a VC fund in Stockholm focused on Software and Health Care. IGC is led and managed by a diverse team whose experience spans a wide range of roles across numerous industry sectors. They are operating executives, strategy consultants, financial advisors, technical experts and equity analysts, but most of all, they are expansion-stage experts. They understand how to fuel growth by attracting great talent,implementing high-caliber boards and building business relationships between companies.
- Total investments:
- 95
- Last investment:
- Lead investor:
- 36%
Last updated:
For AI agents: llms.txt
Industries Investor Growth Capital Limited invests in
Stages Investor Growth Capital Limited invests in
Countries Investor Growth Capital Limited invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Tom Johnstone
|
|||
Gunnar Brock
|
|||
Michael Oporto
|
|||
Peter Wallenberg
|
Investment Focus
Industry
- Software 17 (18%)
- Health Care 17 (18%)
- Medical 13 (14%)
- Enterprise Software 13 (14%)
- Biotechnology 12 (13%)
Stage
- Series C 21 (22%)
- Series B 17 (18%)
- Funding Round 16 (17%)
- Series D 12 (13%)
- Series E 9 (9%)
Country
- United States 58 (61%)
- Sweden 3 (3%)
- China 1 (1%)
- Israel 1 (1%)
- South Africa 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Hans Stråberg
Director
|
Director | Total investments: 2 | Find email | |
|
Tom Johnstone
Director
|
Director | Total investments: 0 | Find email | |
|
Gunnar Brock
Director
|
Director | Total investments: 0 | Find email | |
|
Michael Oporto
Managing Director & CFO
|
Managing Director & CFO | Total investments: 0 | Find email | |
|
Peter Wallenberg
Honorary Chairman
|
Honorary Chairman | Total investments: 0 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
PE Student Trips
|
PE Student Trips offers educational trips and travel opportunities for students, providing them with a platform to explore new destinations and enhance their learning experiences outside the classroom. | $48K / Series A / May 01, 2023 | |
Intuity Medical
|
Intuity Medical develops blood glucose monitoring systems for diabetes management. Their POGO Automatic Blood Glucose Monitoring System is the world’s first FDA-cleared automatic, one-step blood glucose meter that combines lancing, blood collection, and analysis into a single 10-test cartridge. It provides a convenient and discreet solution formillions of patients who need to regularly test their blood glucose.The company was founded in 2002 and is headquartered in Fremont, California. | $70M / Jan 08, 2018 | |
Neuronetics
|
Neuronetics is focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. They are the first and only company to have a non-systemic and non-invasive depression treatment cleared by the FDA for patients who have not benefited from prior antidepressant treatment. | $15M / Series G / Jun 06, 2017 | |
Spigit
|
Spigit is the largest provider of innovation management software to some of the world’s foremost companies, including AT&T, Citibank, Duke Energy, MetLife, Pfizer, Unilever, UnitedHealth Group and more. Spigit has powered innovation and process improvement for large enterprises across major industries of financial services, manufacturing,healthcare, and energy. Spigit cloud software enables organizations to engage with their employees, customers, and partners to build a culture of innovation. Spigit proprietary automation, patented algorithms, and highly configurable, secure and multi-lingual platform make it the only solution that will scale seamlessly across the enterprise. Spigit global HQ is in San Francisco, European HQ in London, and our Asia-Pacific HQ is in Sydney. Learn more at www.spigit.com. | $13M / Oct 27, 2015 | |
HireVue
|
HireVue is transforming the way companies discover and hire the best talent with its AI-driven Hiring Intelligence platform. Combining predictive, validated industrial/organizational science with artificial intelligence allows recruiting professionals to augment human decision-making in the hiring process, delivering higher quality talent,faster. HireVue has hosted over six million interviews for more than 700 customers worldwide, including more than one-third of the Fortune 100 and leading brands such as Vodafone, Nike, Intel, Hilton, HealthSouth, Qantas and Carnival Cruise Lines. | $45M / Series E / Jun 02, 2015 | |
Conductor
|
Conductor is the world's leading organic marketing company. Our content intelligence platform, Conductor Searchlight, generates customer intent insights that lead to compelling content, increased traffic, and higher organic marketing ROI. Conductor's technology enables marketers to understand their prospective customers' intent byrevealing the trends and topics they are searching for at every phase of purchase process. Customizable dashboards and workflows guide marketers through the content creation process, empowering them to continuously measure, refine, and demonstrate the effectiveness of their SEO and content marketing efforts. Conductor's forward-thinking customers include global brands like Citibank and FedEx, emerging leaders like Birchbox and JustFab, and leading agencies like iProspect and Acronym. In December 2019, Conductor spun out of WeWork and is now an independent company. | $27M / Series D / Feb 12, 2015 | |
Mindjet
|
Mindjet is committed to enterprise innovation excellence. We provide the first software platform with the capability to drive repeatable business innovation at scale. Our enterprise-ready innovation management suite, featuring SpigitEngage and our mind mapping software, MindManager, is used by millions and over 83% of the Fortune 100. We enable theworld's leading brands to build and manage sustainable innovation programs with social dynamics, purposeful collaboration, crowd science, and analytics to surface and develop the best ideas then bring them to market. Mindjet is headquartered in San Francisco with offices throughout the US, UK, France, Germany, Japan, and Australia. | $10M / Debt Financing / Nov 10, 2014 | |
Guavus
|
Guavus solves the world’s most complex data problems. Proven across Fortune 500 enterprises, Guavus provides a new generation of analytically powered big data applications to address specific business problems for next-generation service assurance, next-generation customer experience management and the Internet of Things. The Company uniquelybreaks down the barriers between Operational Support Systems and Business Support Systems to enable customers to more efficiently plan network capacity, improve service operations and deliver a better customer experience. Guavus’ operational intelligence applications correlate and analyze massive amounts of streaming and stored business, operational and sensor data from multiple, disparate source systems in real time. Guavus products currently process more than two Trillion transactions per day. | $20M / Debt Financing / Aug 21, 2014 | |
Acquia
|
Acquia provides a cloud platform for building that delivering and optimizes digital experiences. With Acquia, organizations around the world including BBC, Nasdaq, Stanford University, and the Australian Government accelerate time to market and drive customer engagement through cross-channel, contextually relevant, and high-impact digitalexperiences.The company was founded in 2007 and is headquartered in Boston, Massachusetts. | $50M / Series F / May 27, 2014 | |
Transcend Medical
|
Transcend Medical is focused on the development of medical devices for the treatment of glaucoma, a cause of adult irreversible blindness. It is estimated that nearly four million people in the US and over 60 million worldwide are afflicted with the disease today and the numbers are expected to grow to nearly six million in the US, and to over 70million worldwide by the year 2015.In 2005, Transcend Medical was the first company to spin out of ForSight Labs, an incubator solely focused on ophthalmic innovations. Transcend Medical was granted CE mark for the CyPass Micro-Stent® in 2008, and is being evaluated in several clinical studies in the US and abroad, including the COMPASS multi-center clinical trial. | $29M / Series C / Apr 02, 2014 | |
| See all 95 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Investor Growth Capital Limited invest in?
Investor Growth Capital Limited invests primarily in Software, Health Care and Medical startups, most often at Series C and Series B stage. Most of the 95 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Investor Growth Capital Limited?
Public channels for Investor Growth Capital Limited include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Investor Growth Capital Limited?
The team at Investor Growth Capital Limited includes Hans Stråberg (Director), Tom Johnstone (Director) and Gunnar Brock (Director), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
